Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Mol Psychiatry. 2014 Oct 7;20(5):647–656. doi: 10.1038/mp.2014.107

Table 1.

SNPs associated with cups of coffee consumed per day among coffee consumers

Locus Index SNPa Closest Gene EA/
NEA
EAF
EUR/AA
Stage 1b
EUR
n ≤ 91,462
Stage 2 b Trans-Ethnic
Meta-Analysisc
EUR
n ≤ 30,062
AA
n ≤ 7,964
β (SE) P β (SE) P β (SE) P β (SE) Log10BF Post
Prob
n
2p24 rs1260326 GCKR T/C .41/.17 −0.04 (0.01) 1.06 ×10−07 −0.03 (0.01) 0.02 −0.01 (0.03) 0.77 −0.04 (0.01) 6.48 0.07 129,417
4q22 rs1481012 ABCG2 A/G .89/.95 0.06 (0.01) 1.13 ×10−06 0.03 (0.02) 0.11 0.16 (0.05) 1.27 ×10−03 0.06 (0.01) 6.08 0.23 126,019
7p21 rs4410790
rs6968554
AHR T/C
A/G
.37/.52
.39/.33
−0.14 (0.01)
−0.13 (0.01)
1.48 ×10−57
2.54 ×10−57
−0.05 (0.01)
−0.07 (0.01)
1.66 ×10−04
2.78 ×10−10
−0.09 (0.02)
−0.05 (0.02)
2.37 ×10−06
0.02
−0.10 (0.01)
−0.10 (0.01)
58.87
69.69
0.96
1.00
116,674
124,849
7q11.23 rs7800944 MLXIPL T/C .72/.67 −0.05 (0.01) 7.82 ×10−09 −0.06 (0.02) 4.20 ×10−04 −0.02 (0.02) 0.37 −0.05 (0.01) 8.83 0.09 116,417
7q11.23 rs17685 POR A/G .29/. 19 0.07 (0.01) 9.06 ×10−14 0.05 (0.01) 1.01 ×10−03 0.07 (0.03) 7.55 ×10−03 0.07 (0.01) 15.12 0.08 115,465
11p13 rs6265 BDNF T/C .19/.07 −0.05 (0.01) 3.40 ×10−07 −0.03 (0.01) 0.07 −0.05 (0.04) 0.25 −0.04 (0.01) 5.76 0.10 127,828
15q24 rs2470893
rs2472297
CYP1A1,
CYP1A2
T/C
T/C
.31/.06
.24/.06
0.12 (0.01)
0.15 (0.01)
6.89 ×10−44
6.45 ×10−47
0.09 (0.01)
0.11 (0.01)
9.92 ×10−11
3.26 ×10−16
0.20 (0.07)
0.19 (0.05)
4.23 ×10−03
8.62 ×10−05
0.12 (0.01)
0.14 (0.01)
57.79
62.77
1.00
0.97
113,273
116,272
17q11.2 rs9902453 EFCAB5 A/G .54/.80 −0.04 (0.01) 2.26 ×10−06 −0.03 (0.01) 9.13 ×10−03 −0.04 (0.03) 0.17 −0.03 (0.01) 6.29 0.05 126,819

Abbreviations: EA, effect allele; NEA, non-effect allele; EAF, effect allele frequency; EUR, European ancestry; AA, African American ancestry; SE, standard error; BF, Bayes-factor, Post Prob, posterior probability

a

Genic SNPs are in bold-face.

b

Effect coefficients (SE), representing cups/day per effect allele, and corresponding P-values from stage 1 fixed-effects meta-analysis (columns 6, 7) and stage 2 fixed-effects meta-analyses (columns 8-11).

c

Effect coefficients (SE), representing cups/day per effect allele, from random-effects meta-analysis of all stage 1 and stage 2 studies (column 12). Log10BF (column 13) and corresponding posterior probabilities (column 14) from trans-ethnic meta-analysis of all stage 1 and stage 2 studies. A posterior probability > 0.5 suggests heterogeneity in allelic effects.